Disability and quality of life in headache: Where we are now and where we are heading

Neurological Sciences

Volumn 34, Issue SUPPL. 1, 2013, Pages

  D'Amico, D ^a   Grazzi, L ^a   Usai, S ^a   Leonardi, M ^a   Raggi, A ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Disability; Headache; Health related quality of life; Patient reported outcome measures (PROMs); Review

Indexed keywords

ARTICLE; CHRONIC DAILY HEADACHE; DISABILITY; EDUCATION PROGRAM; EPISODIC MIGRAINE; HEADACHE; HUMAN; LONGITUDINAL STUDY; MIGRAINE WITHOUT AURA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIMARY HEADACHE; QUALITY OF LIFE; SURGICAL APPROACH; TRANSFORMED MIGRAINE; REVIEW; COMPLICATION;

HEADACHE; HUMANS; QUALITY OF LIFE;

EID: 84883407667     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1378-9     Document Type: Article

References (24)

1. Buse DC, Rupnow MF, Lipton RB (2009) Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc 84:422-435
2. Raggi A, Giovannetti AM, Quintas R, D'Amico D, Cieza A, Sabariego C, Bickenbach JE, Leonardi M (2012) A systematic review of the psychosocial difficulties relevant to patients with migraine. J Headache Pain 13:595-606
3. D'Amico D, Grazzi L, Usai S, Raggi A, Leonardi M, Bussone G (2011) Disability in chronic daily headache: state of the art and future directions. Neurol Sci 32:S71-S76
4. Lantéri-Minet M, Duru G, Mudge M, Cottrell S (2011) Quality of life impairment, disability, and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 31:837-850
5. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50:921-936
6. Beran RG, Spira PJ (2011) Levetiracetam in chronic daily headache: a double-blind, randomised placebo-controlled study. (The Australian KEPPRA Headache Trial [AUS-KHT]). Cephalalgia 31:530-536
7. Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, Himawan L (2010) Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ 341:c4871
8. Seng EK, Holroyd KA (2012) Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial. Cephalalgia 32:390-400
9. Guyuron B, Kriegler JS, Davis J, Amini SB (2011) Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg 127:603-608
10. Faber C, Garcia RM, Davis J, Guyuron B (2012) A socioeconomic analysis of surgical treatment of migraine headaches. Plast Reconstr Surg 129:871-877
11. Serra G, Marchioretto F (2012) Occipital nerve stimulation for chronic migraine: a randomized trial. Pain Physician 15:245-253
12. Novack V, Fuchs L, Lantsberg L, Kama S, Lahoud U, Horev A, Loewenthal N, Ifergane G (2011) Changes in headache frequency in premenopausal obese women with migraine after bariatric surgery: a case series. Cephalalgia 31:1336-1342
13. Raggi A, Leonardi M, Bussone G, D'Amico D (2011) Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life. Neurol Sci 32(3):387-392
14. Raggi A, Leonardi M, Bussone G, D'Amico D (2013) A 3-month analysis of disability, quality of life, and disease course in patients with migraine. Headache 53:297-309
15. Smith TR, Nicholson RA, Banks JW (2010) Migraine education improves quality of life in a primary care setting. Headache 50:600-612
16. Voigt K, Liebnitzky J, Burmeister U, Sihvonen-Riemenschneider H, Beck M, Voigt R, Bergmann A (2011) Efficacy of osteopathic manipulative treatment of female patients with migraine: results of a randomized controlled trial. J Altern Complement Med 17:225-230
17. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN (2000) Validity of the migraine disability assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain 88:41-52
18. Kosinski M, Bayliss MS, Bjorner JB, Ware JE Jr, Garber WH, Batenhorst A, Cady R, Dahlöf CG, Dowson A, Tepper S (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12:963-974
19. Jhingran P, Osterhaus JT, Miller DW, Lee JT, Kirchdoerfer L (1998) Development and validation of the migraine-specific quality of life questionnaire. Headache 38:295-302
20. Ware JE (2000) SF-36 health survey update. Spine 25:3130-3139
21. Katić BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME (2010) Adherence to acute migraine medication: what does it mean, why does it matter? Headache 50:117-129
22. D'Amico D, Tepper SJ (2008) Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat 4:1155-1167
23. Tfelt-Hansen P, Pascual J, Ramadan N, Dahlöf C, D'Amico D, Diener HC, Hansen JM, Lanteri-Minet M, Loder E, McCrory D, Plancade S, Schwedt T; International Headache Society Clinical Trials Subcommittee (2012) Guidelines for controlled trials of drugs in migraine: 3rd edn. A guide for investigators. Cephalalgia 32(1):6-38
24. Silberstein S, Tfelt-Hansen P, Dodick DW, Limmroth V, Lipton RB, Pascual J, Wang SJ; Task Force of the International Headache Society Clinical Trials Subcommittee (2008) Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 28(5):484-495